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Abstract
The organization of the axonal cytoskeleton is a key determinant of the normal function of an
axon, which is a long thin projection away from a neuron. Under normal conditions two axonal
cytoskeletal polymers microtubules and neurofilaments align longitudinally in axons and are
interspersed in axonal cross-sections. However, in many neurotoxic and neurodegenerative
disorders, microtubules and neurofilaments segregate apart from each other, with microtubules
and membranous organelles clustered centrally and neurofilaments displaced to the periphery.
This striking segregation precedes abnormal and excessive neurofilament accumulation in these
diseases, which in turn leads to focal axonal swellings. While neurofilament accumulation
suggests the impairment of neurofilament transport along axons, the underlying mechanism of
their segregation from microtubules remains poorly understood for over 30 years.To address this
question, we developed a stochastic multiscale model for the cross-sectional distribution of
microtubules and neurofilaments in axons. The model describes microtubules, neurofilaments
and organelles as interacting particles in a 2D cross-section, and is built upon molecular
processes that occur on a time scale of seconds or shorter. It incorporates the longitudinal
transport of neurofilaments and organelles through this domain by allowing stochastic arrival
and departure of these cargoes, and integrates the dynamic interactions of these cargoes with
microtubules mediated by molecular motors. Simulations of the model demonstrate that
organelles can pull nearby microtubules together, and in the absence of neurofilament transport,
this mechanism gradually segregates microtubules from neurofilaments on a time scale of hours,
similar to that observed in toxic neuropathies. This suggests that the microtubule-neurofilament
segregation is simply a consequence of the selective impairment of neurofilament transport. The
model generates the experimentally testable prediction that the rate and extent of segregation
will be dependent on the sizes of the moving organelles as well as the density of their traffic.
Author Summary
The shape and function of axons is dependent on a dynamic system of microscopic intracellular
protein polymers (microtubules, neurofilaments and microfilaments) that comprise the axonal
cytoskeleton. Neurofilaments are cargoes of intracellular transport that move along microtubule
tracks, and they accumulate abnormally in axons in many neurotoxic and neurodegenerative
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disorders. Intriguingly, it has been reported that neurofilaments and microtubules, which are
normally interspersed in axonal cross-sections, often segregate apart from each other in these
disorders, which is something that is never observed in healthy axons. Here we describe a
stochastic multiscale computational model that explains the mechanism of this striking
segregation and offers insights into the mechanism of neurofilament accumulation in disease.
Introduction
Axons are long slender projections of nerve cells that permit fast and specific electrical
communication with other cells over long distances. The ability of nerve cells to extend and
maintain these processes is critically dependent on the cytoskeleton, which is a dynamic scaffold
of microscopic protein polymers found in the cytoplasm of all eukaryotic cells. The axonal
cytoskeleton comprises microtubules, intermediate filaments called neurofilaments, and
microfilaments. Microtubules and neurofilaments are both long polymers that align in parallel
along the long axis of the axon, forming a continuous overlapping array that extends from the
cell body to the axon tip [1, 2]. Microtubules are stiff hollow cylindrical structures about 25 nm
in diameter that serve as tracks for the long-range bidirectional movement of intracellular
membranous organelles and macromolecular cargo complexes. In axons, this movement is
known as axonal transport [3]. The cargoes of axonal transport are conveyed by microtubule
motor proteins: kinesins in the anterograde direction (towards the axon tip), and dyneins in the
retrograde direction (towards the cell body) [4]. Neurofilaments, which are the intermediate
filaments of nerve cells, are flexible rope-like polymers that measure about 10 nm in
diameter [5]. These polymers function as space-filling structures that expand axonal
cross-sectional area, thereby maximizing the rate of propagation of the nerve impulse [6, 7]. In
large axons, neurofilaments are the single most abundant structure and occupy most of the
axonal volume [8]. Mutant animals that lack neurofilaments develop smaller caliber axons and
exhibit delayed conduction velocities [9–11].
In addition to their structural role in axons, neurofilaments are also cargoes of axonal
transport, moving along microtubule tracks powered by kinesin and dynein motors [13–16, 126].
The filaments move at rates similar to membranous organelles but the movements are less
frequent, resulting in a “stop and go” motile behavior characterized by short bouts of movement
interrupted by prolonged pauses on a time scale of seconds or shorter [17, 18]. The net result is
an average rate of transport that is much slower than that for many other cargoes.
Neurofilaments has been observed to accumulate abnormally in axons in many
neurodegenerative diseases including amyotrophic lateral sclerosis, hereditary spastic paraplegia,
giant axonal neuropathy and Charcot-Marie-Tooth disease (also known as hereditary distal
motor and sensory neuropathy) [5, 19–23], and also in many toxic neuropathies [24–28]. In
extreme cases, these accumulations can lead to giant balloon-like axonal swellings [29–34].
These accumulations are thought to be caused by alterations in neurofilament transport, but the
mechanism is not understood [35–40].
In healthy axons, microtubules and neurofilaments align along the length of an axon and are
interspersed in axonal cross-sections [1, 41, 42, 143], with microtubules often forming small
clusters in the vicinity of membranous organelles [8, 44, 45]. However, in many toxic and
neurodegenerative disorders these polymers segregate, with microtubules and membranous
organelles typically clustered in the center of the axon, and neurofilaments displaced to the
periphery (Fig. 1). This striking cytoskeletal reorganization, which is never observed in healthy
axons, has been reported in neurodegenerative disorders as diverse as giant axonal
neuropathy [46–48] and Charcot-Marie-Tooth disease [34, 49], as well as in neurotoxic
neuropathies induced by exposure to agents as diverse as 2,5-hexanedione and
3,3’-iminodiproprionitrile (IDPN) [24, 51–57, 131], aluminum [58], carbon disulfide [59, 60],
estramustine phosphate [61], 1,2-diacetylbenzene [62] and 1,2,4-triethylbenzene [63], and in a
transgenic mouse expressing a mutant neurofilament protein [64]. However, the mechanism of
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this segregation and its relationship to the neurofilament accumulation that also occurs in these
different conditions is not known.
A B 
C D 
Figure 1. Cross-sectional distributions of microtubules and neurofilaments via electron
microscopy. (A) Schematic drawing that illustrates the normal distribution of microtubules
(large black dots), neurofilaments (small grey dots) and organelles (cyan disks) in untreated
axons. (B) Schematic drawing that illustrates the segregated components in IDPN-treated axons.
(C) In normal axons microtubules, neurofilaments and organelles are interspersed. Big dots:
microtubules; small dots: neurofilaments; circular objects: organelles. (D) In IDPN-treated
axons these components segregate in a core-tube pattern, with microtubules and organelles
typically in the center and neurofilaments displaced to the periphery. The scale bars are 1 µm.
Reproduced from Papasozomenos et al, 1981. Originally published in Journal of Cell Biology,
91:866-871.
Microtubule-neurofilament segregation has been studied most extensively for IDPN and
2,5-hexanedione. IDPN is a compound closely related to the naturally occurring food poison
3-aminopropionitrile which causes the neurological disorder lathyrism [65–68], and
2,5-hexanedione is a metabolite of the industrial solvent hexane. The mechanism of toxicity is
not known, but it is thought to involve chemical modification of neurofilaments, which
presumably disrupts their normal interactions with microtubules in some way [25, 28, 69–74].
Systemic administration of IDPN or 2,5-hexanedione to rats causes selective impairment of
neurofilament transport [75–79], focal accumulations of axonal neurofilaments leading to axon
enlargement, and neurological defects similar to amyotrophic lateral sclerosis (ALS) in
humans [80–83]. Injection of IDPN or 2,5-hexanedione into peripheral nerves results in local
microtubule-neurofilament segregation within just a few hours, preceding the accumulation of
neurofilaments by hours or days [51, 52, 56, 84, 131]. This segregation does not appear to affect
the axonal transport of membranous organelles, which continue to interact with and move along
these tracks in spite of their clustering. Moreover, in the case of IDPN the segregation has been
shown to be reversible [24, 131], as has the impairment of neurofilament transport [85]. In [24],
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a single injection of IDPN into rat sciatic nerves resulted in segregation in axons at the injection
site within a few hours, but the segregation disappeared in about a day. In [131], a single
injection of IDPN into the body cavity of rats resulted in segregation within the axons of the
sciatic nerve after 4 days, and this disappeared after six weeks. Thus the
microtubule-neurofilament segregation caused by IDPN and 2,5-hexanedione is fast, local and
reversible.
Though the segregation of microtubules and neurofilaments in axons was first described
more than 30 years ago, the underlying mechanisms are still poorly understood. Given that
neurofilaments move along microtubule tracks and that microtubule-neurofilament segregation
precedes neurofilament accumulation and axonal enlargement in rodent models, it is attractive to
speculate that the segregation reflects an uncoupling of neurofilaments from their transport
machinery [75]. However, the mechanism by which such an uncoupling at the molecular level
might generate polymer segregation at the population level remains unclear.
To address these questions, we have developed a stochastic multiscale model for the
cross-sectional organization of microtubules and neurofilaments in axons. The model describes
microtubules, neurofilaments, and organelles as interacting particles that move in a 2D domain
representing a cross-section of an axon, and incorporates axonal transports of neurofilaments
and organelles, as well as volume exclusion and Brownian motion of all the particles.
Neurofilaments and organelles dynamically bind to and unbind from nearby microtubules
through molecular motors, and the motor cross-bridges are modeled as elastic springs. The
longitudinal movement of neurofilaments and organelles along axons is modeled by stochastic
addition and removal of these cargoes. The multiscale nature of the model lies in that it is built
upon molecular processes that occur on a time scale of seconds or fractions of a second, and
addresses segregation phenomena of two populations of polymers that occur on a time scale of
hours to days.
Simulations of the model demonstrate that if we block neurofilament transport by preventing
neurofilament from binding to microtubules, then organelles pull nearby microtubules together
and gradually segregate them from neurofilaments, on the same time course as observed in toxic
neuropathies; while if we restore neurofilament transport, then microtubules and neurofilaments
start to remix until their spatial distribution returns to normal. The model further predicts that (1)
during the segregation process, microtubules first form small clusters, small clusters merge into
bigger clusters, and eventually a single cluster forms close to the center of the domain; (2) in the
absence of neurofilament transport, larger organelles are more effective in causing complete
cytoskeletal segregation than small organelles with the same density.
Model
The stochastic multiscale model
In our model, microtubules, neurofilaments and organelles are described as individual particles
that move in a circular domain D with fixed radius R0, representing a cross-section of an axon.
Microtubules and neurofilaments are rod-like polymers that align along the length of axons, thus
they are treated as nondeformable disks in D (Fig. 2A), with center positions denoted by
xki = (x
k
i , y
k
i ) and radii by r
k
i . Here k = M or N is the index for particle type: M for
microtubule, N for neurofilament; and i with 0 ≤ i ≤ nk is the index for the k-type particle
where nk is the total number of k-type particles. The radii of microtubules and neurofilaments
are constant, with rMi = 12.5 nm and r
N
i = 5 nm. Organelles in axons have different sizes and
shapes, and their cross-sectional geometry depends on their position relative to the cross-section
(Fig. 2B). In this model, we took organelles as spindle-shaped objects and, for simplicity, we did
not consider possible shape changes (Fig. 2C). Therefore the organelles exist as non-deformable
disks in D, and as an organelle crosses D, its cross-sectional radius, rOi , varies according to its
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position, zOi , relative to D,
rOi = b
(
1− (z
O
i )
2
a2
)
, −a ≤ zOi ≤ a. (1)
Here a is half of the organelle length, b is its maximum cross-sectional radius, zOi is the distance
of its center to D, and the index “O” stands for organelle. By varying the parameters a and b, we
can vary the overall dimension of the organelles (Fig. 2C).
We examined three key molecular mechanisms that contribute to the cross-sectional
distribution of microtubules and neurofilaments: slow axonal transport of neurofilaments, fast
axonal transport of organelles, and volume exclusion of all the particles. In the following
sections we describe in detail how these mechanisms were incorporated into our model. We
denote the unit vector pointing from xki to x
l
j by e
kl
ij , and the surface distance between the i-th
particle of k-type and j-th particle of l-type by dklij , given as,
dklij = |xki − xlj | − rki − rlj . (2)
Mechanism 1: Slow axonal transport of neurofilaments.
Neurofilaments interact with molecular motors (kinesin and dynein) which move these polymers
along microtubules either anterogradely or retrogradely [14, 16, 86, 87]. The movements are fast
but infrequent because the filaments spend most of their time pausing, which results in a slow
average rate of transport [88, 126]. This longitudinal movement of neurofilaments along
microtubules can change the spatial distribution of these polymers in axonal cross-sections. For
example, if a neurofilament moves into the cross-section along a microtubule in a small cluster
of microtubules it can displace one or more of the adjacent microtubules, dispersing the cluster.
Alternatively, if a neurofilament between two microtubules moves out of the cross-section, then
the two microtubules are able to diffuse closer together.
DAxon 
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Figure 2. Model setup. (A) The model geometry. The computational domain D represents a
cross-section of an axon. The black circle is the domain boundary representing the axon
membrane. Small grey dots are neurofilaments (NF), large black dots are microtubules (MT)
and cyan filled disks are organelles (Org). (B) The relation of D to the whole axon. Thin grey
lines are neurofilaments, thick black lines are microtubules, the cyan body is an organelle, red
triangles represent molecular motors that move microtubules and organelles along microtubule
tracks. (C) The shape of organelles considered in this model. The cross-sectional radius of an
organelle in D depends on its position relative to D.
Based on the above considerations, we modeled neurofilament transport in the following
way. A neurofilament in D can bind to a microtubule within a binding radius Rb with rates kNon.
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A neurofilament bound to a nearby microtubule can unbind with rate kNoff , or move away and
exit D with rate kNout. We conserved neurofilament number in D by replacing each departing
neurofilament with a new entering neurofilament, placed at a distance Rb from a randomly
selected microtubule. Neurofilaments and microtubules are long polymers that are aligned in
parallel along the long axis of the axon so a new neurofilament can only enter D if a
neurofilament was present at that location in the adjacent plane at the preceding time point.
Thus, to prevent the entry of a new neurofilament in a region of D that is lacking other
neurofilaments (specifically, this would be encountered when simulating the remixing of
neurofilaments and microtubules after segregation), we only permitted the entry of a new
neurofilament next to a microtubule that was already within a radius Rb of another
neurofilament. We did not differentiate the direction of neurofilament movement along the axon
because anterograde and retrograde movements have similar contributions to the distribution of
neurofilaments in D. If a neurofilament is bound to a microtubule, they interact through the
following elastic spring forces,
GMNi,j = −GNMj,i = κNdMNij eMNij . (3)
Here GMNi,j and G
NM
j,i are the forces acting on the i-th microtubule by the j-th neurofilament
and vice versa, and κN is the spring constant. If dMNij is bigger than the binding radius Rb, then
there is no spring force between the neurofilament-microtubule pair.
We assumed that each neurofilament could engage with only one microtubule at a time. The
rationale for this is as follows. The on-rate and off-rate for neurofilament binding to
microtubules is estimated to be 10−2/s and 6.5× 10−2/s based on previous experiments. Thus
a neurofilament within the binding radius of a microtubule would spend, on average,
1/(1 + 6.5) ≈ 0.13 of its time engaged with that microtubule, and the chance for one
neurofilament within the binding radius of two microtubules to bind both simultaneously would
be 0.132 ≈ 0.017. Since in reality no neurofilament would remain within the binding radius of
two microtubules at all times, the actual probability is even lower. Thus the chance for one
neurofilament to interact with multiple microtubules simultaneously is negligible and we neglect
it in our model.
Mechanism 2: Fast axonal transport of organelles.
Like neurofilaments, membraneous organelles are also conveyed anterogradely or retrogradely
along microtubule tracks by kinesin and dynein motors. However, these cargoes tend to spend
much less time pausing, resulting in a much faster average rate of transport. Due to their large
size, the movement of organelles can cause significant fluctuations of the microtubule and
neurofilament organization by displacing these polymers laterally. These cargoes can bind
multiple motors [89, 90] and, due to their large size, they can readily interact with multiple
microtubules even if those microtubules are not close to each other [45, 91]. As an organelle
moves along several microtubules, it can pull them closer together, similar to a “zipper”. This
speculation is supported by in vivo data that demonstrate organelles being surrounded by
multiple microtubules in close proximity [8, 44, 45, 91], and in vitro experiments [92] which
show that motors bound to spherical cargoes can pull on multiple microtubules and align them.
Based on the above considerations, we modeled organelle movement in D in the following
way. Organelles enter D randomly with rate kOin, moving along randomly chosen microtubules,
and move persistently until they leave D completely. Thus each organelle is present in D for a
time period that equals its length (2a) divided by its speed sO, and
zOi = −a+ sOt, 0 ≤ t ≤ 2a/sO, (4)
where t is the time the organelle has been present in D. As the organelle moves from one side of
D to the other, its cross-sectional radius rOi first increases from 0, reaches its maximum when it
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is halfway through, and then decreases to 0, which is given by Eqn (1). While present in D, an
organelle can bind stochastically to an available microtubule within a binding radius Rb with
rate kCon and unbind with rate k
C
off . If an organelle and a microtubule are bound, they interact
through the linear spring force,
GMFi,j = −GFMj,i = κOdMFij eMFij . (5)
Here GMFi,j and G
FM
j,i are the forces acting on the i-th microtubule by the j-th organelle and
vice versa, and κO is the effective spring constant which represents the action of possibly
multiple motors.
Mechanism 3: Volume exclusion.
In addition to the active movement of neurofilaments and organelles and their interactions with
microtubules through molecular motors, all the particles in the system interact through forces of
volume exclusion.
Neurofilaments have sidearms which are highly-charged unstructured polypeptide domains.
These sidearms project outward from the filament core to form an entropic brush that defines a
zone of exclusion around the polymer via long-range repulsive forces [93–97], maximizing the
space-filling properties of these cytoskeletal elements. Microtubule associated proteins such as
tau also have highly charged long polypeptide domains that can have a similar volume-excluding
effect [93, 98–100]. Based on these biological considerations, we modeled volume exclusion of
neurofilaments, microtubules and organelles through the following pairwise repulsions,
Rkli,j =
 − ε
kl
(
Lr
/
dklij − 1
)
eklij if d
kl
ij ≤ Lr
0 if dklij > Lr.
(6)
Here Rkli,j is the force acting on the i-th particle of k-type by the j-th particle of l-type, where
k, l = M,N or O, 1 ≤ i ≤ nk, and 1 ≤ j ≤ nl. For example, RMNi,j is the force acting on the
i-th microtubule by the j-th neurofilament. Here Lr is the maximum interaction distance; εkl
specifies the magnitude of the force; and the negative sign preceding εkl indicates that the force
is repulsive. We note that this force goes to infinity as the surfaces of two particles approach
each other and remains zero if the distance between two particles is larger than Lr. The
functional form of the force is similar to those used in [101, 122] for neurofilament repulsions
and matches recent experimental data [103].
To keep all the particles inside the domain, we modeled volume exclusion of the particles
with the domain boundary in a similar way. The force acting on the i-th particle of k-type by the
axonal membrane is given by
RkBi =
 − ε
kB
(
Lr
/
dkBi − 1
)
ekBi if d
kB
i ≤ Lr
0 if dkBi > Lr.
(7)
Here the index B stands for “boundary”, dkBi = R0 − |xki | − rk, and ekBi is the unit vector
pointing from the center of the domain to xki .
Microtubules, neurofilaments, and organelles can also interact with each other
hydrodynamically through the axoplasm. Organelle movement can cause significant flow of the
axoplasm near their surfaces and displace nearby microtubules and neurofilaments. As an
organelle pushes into D, its radius increases and it pushes nearby fluid and particles away from
itself; as it moves away from D, instead of leaving void behind it, it creates negative pressure
which draws the axoplasm to flow back and fill the space. The hydrodynamic effect due to the
movement of microtubules and neurofilaments is presumable smaller given their constant and
smaller size in cross-section. In this model, we do not model the hydrodynamic interactions
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among these particles explicitly, but include this effect by adjusting the force prefactors
associated with organelles. Specifically, when an organelle push into the domain, we double εkO
and εOk to take into account the contribution of the fluid flow it creates.
Model equations.
The movements of microtubules, neurofilaments, and organelles in axons are viscous-dominated
and thus inertia can be neglected. Under this simplification, we have the following system of
stochastic differential equations
dxki = F
k
i /µ
k dt + σk dWki , 1 ≤ i ≤ nk, k = M,N,F. (8)
Here Fki is the sum of all applied forces on that particle specified in (3), (5), (6) and (7). For
example, FNi =
∑
jG
NM
i,j +
∑
jR
NM
i,j +
∑
j, j 6=iR
NN
i,j +
∑
jR
NO
i,j +R
NB
i . The constant
µk denotes the drag coefficient of the k-type particle. Finally Wki are independent 2D Wiener
processes modeling the random motion of these particles, and the amplitude σk is given by
σk =
√
2Dk, where Dk is the diffusion coefficient of the particle calculated by the Einstein
relation.
Parameter estimation and simulation algorithm
The parameters used in our model are physical, and thus they are all measurable. Most of them
have already been measured or there exist experiments that can be used to estimate them. Table
1 summarizes all the parameter values, and the detailed methods to obtain these parameters are
given in the SI. The units of these parameters reflect the time scales for the molecular processes
integrated into the model, which are seconds or fractions of a second.
To solve the model numerically, we treated the binding and unbinding, arrival and departure
of cargoes explicitly at discrete time steps, and integrated the model system (8) using the explicit
Euler’s method. Because σk, k = M,N,C are constant in time, the numerical integrator has
strong order 1.0 [147]. We chose a time step h much smaller than all the time scales involved in
Mechanisms 1-3. For the simulations of segregation and remixing over hours to a day, we used
h = 1/50 sec if there was no organelle in D, and h = 1/1600 sec otherwise in order to deal
with the stiffness of the equations introduced by the pushing of organelles when they move into
D. The detailed simulation algorithm is included in the SI. The computational tool is written in
C++.
Results
The organization of neurofilaments in normal axons.
Morphometric studies suggest that neurofilaments are spaced randomly in axonal cross-sections
when packed at low densities, but as the density increases they start to experience the
volume-exclusionary repulsive forces of their neighbors and assume a less random distribution
characterized by a more even neurofilament spacing [41, 122, 143]. In this section we
demonstrate that the neurofilament distribution generated using our model agrees well with
these experimental data.
Different methods have been used to characterize neurofilament distribution in axonal
cross-sections. Kumar et al [122] used the radial distribution function (RDF) (also known as the
pairwise correlation function). The RDF, denoted as g(r) describes how density varies as a
function of distance from a reference particle. For particles that move randomly and completely
independently, g(r) is a constant value of 1; while for crystalline structures g(r) forms peaks at
precisely defined intervals. For neurofilaments in axons the shape of g(r) typically lies between
8
Table 1. Model Parameter Values
Parameter Description Values Notes and Refs
rN Radius of neurofilament backbone 5 nm [3, 105, 106]
rM Radius of microtubule backbone 12.5 nm [3]
Rb capturing radius for microtubule-cargoes
active binding
80 nm [123]
kNon rate for neurofilament binding 1.0× 10−2/s [108], E.E.
kNoff rate for neurofilament unbinding 6.5× 10−2/s [108]
kNout rate for neurofilament departure 0.1 s
−1 E.E
kOon rate for organelle binding 2/s [128, 129]
kOoff rate for organelle unbinding 2/s [128]
kOin rate for organelle passage 0.105/s [130, 131], E.E.
sO speed of organelle movement along mi-
crotubules
1µm/s [112]
Lr characteristic repulsion distance 121.2 nm [122], E.E.
εr repulsion scale ( = εNN ) 0.5 pN E.E.
κN effective spring constant for microtubule-
neurofilament binding
0.18pN/nm [137], E.E.
κO effective spring constant for organelle-
microtubule binding
0.9pN/nm [137], E.E.
µN drag coefficient of neurofilaments 73.5 pN · s/µm E.E
µM drag coefficient of microtubules 512 pN · s/µm E.E
µO drag coefficient of organelles 40.3pN · s/µm E.E
DN diffusion coefficient of neurofilaments 5.59× 10−5µm2/s E.E.
DM diffusion coefficient of microtubules 8.02× 10−6µm2/s E.E.
DF diffusion coefficient of organelles 1.02× 10−4µm2/s E.E.
E.E.: estimated from experiments; see SI for detailed information.
these two extremes, increasing sharply from 0 and forming a peak around 30− 50 nm [122].
Another method used often is to calculate the occupancy probability distribution (OPD), which
is the distribution for the number of particles within an observation window of a specified shape
and size [41, 122, 143]. For neurofilaments, the OPD can be approximated by
Guassian [122, 143].
In previous experimental studies, the RDF and OPD of neurofilaments were calculated in
selected regions of axonal cross-sections with almost no microtubules and organelles. To mimic
such conditions, we performed simulations with exclusively neurofilaments, i.e., nM = nO = 0,
and thus the only acting mechanisms are the pairwise repulsions and the Brownian motion of
neurofilaments. We used a square domain with side length 1µm, and to minimize the effect of
the boundary we used periodic boundary conditions. Under such conditions, the system (8)
reduces to
dxNi =
∑
j,j 6=i
RNNi,j /µ
N dt + σN dWNi , 1 ≤ i ≤ nN.
We initially put neurofilaments on a hexagon lattice inside the domain, and then ”randomized”
the distribution by simulating the model for sufficient time to observe no further change in the
OPD or RDF. To solve the model, we used the explicit Euler’s method with a time step
h = 1/200 sec.
We first investigated how the neurofilament distribution depends on its density. We took
εNN = 0.5pN and used increasing neurofilament densities of 200 and 400 per µm2 (Fig. 3,
Rows A and B). For each case, the left panel is a plot of the coordinates of the neurofilaments
after randomizing for 25 sec; the middle panel is a plot of the RDF which represent averages
over 50 time frames between 25 sec and 30 sec; and the right panel is a plot of the averaged
9
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Figure 3. Simulated neurofilament distributions with different densities and repulsion
magnitudes. Left: snapshots of neurofilament positions after randomizing for 25 sec. Middle:
the radial distribution functions (RDF, g(r)). Right: the bars are histograms of the occupancy
probability distribution (OPD, pn) using randomly chosen circular windows with a radius 60 nm,
and the black curves are their Gaussian fits. Middle and right plots represent averages over 50
time frames between t = 25 sec and t = 30 sec. In all cases, ε is short for εNN . (A) nF = 200,
εNN = 0.5 pN; (B) nF = 400, εNN = 0.5 pN; (C) nF = 400, εNN = 0.25 pN. Other
parameters are the same as specified in Table 1.
OPD and its Gaussian fit. The methods that we used to calculate the RDF and OPD are the same
as in [122] and described in the supporting information (SI). These plots show that as the
neurofilament density becomes higher, the separation of the peaks of the RDF becomes smaller,
and the average and variance of the OPD becomes larger as the neurofilament density becomes
larger. General features of these plots are in tight agreement with experimental data presented
in [41, 122, 143].
The magnitude of the repulsion between two neurofilaments depends on the charges of their
sidearms. As the phosphorylation level of their sidearms becomes higher, their mutual repulsion
becomes larger. We next investigated how the neurofilament distribution depends on the effect
of sidearm phosphorylation by fixing the neurofilament density and varying εNN . We took the
neurofilament density to be 400 per µm2, and εNN to be 0.25pN and 0.5pN. Fig. 3B and C
shows that as εNN becomes larger, the locations of neurofilaments become more regular, the
peaks of the RDF are better defined, and the variance of the OPD becomes smaller.
Impairment of neurofilament transport leads to
microtubule-neurofilament segregation.
To investigate the mechanism of microtubule-neurofilament segregation in axons, we compared
our simulations to experimental data obtained for IDPN in laboratory animals. We focused on
IDPN because there is published data on both the rate and reversibility of the segregation. When
IDPN is administered transiently by local injection into peripheral nerves, segregation appears
within 2-6 hours and then disappears within 24 hours [24, 57, 131].
Since neurofilament accumulation and axonal swelling occur on a much slower time course
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Figure 4. Reversible segregation of microtubules and neurofilaments. neurofilament transport
is blocked starting at t = 1 h and restored at t = 13 h. (A-F) Snapshots of the positions of
microtubules, neurofilaments and organelles at t = 1 h, 3 h, 6 h, 12 h, 14 h, 20 h. All panels are
from a single realization of the model. (A) microtubules and neurofilaments form a mixture
under normal conditions. (B-D) blockage of neurofilament transport leads to gradual segregation
of microtubules and neurofilaments. (E,F) restoration of neurofilament transport causes
remixing of microtubules and neurofilaments. Small grey dots are free neurofilaments; small
purple dots are neurofilaments engaged with microtubules; large black dots are microtubules;
large blue circles are organelles. Parameters used: nM = 56, nN = 361. Neurofilament on-rate
kNon equals 0 between t = 1 h and 13 h. All other parameters are the same as in Table 1.
than the segregation, they can be ignored for the purposes of our current analysis. Therefore, for
simplicity, we took D to be a disk with fixed radius R0 = 1µm, and set the total number of
neurofilaments nN to be constant. Specifically, if a neurofilament that was engaged with a
microtubule left D, then it was replaced by a new neurofilament that entered D by association
with a new randomly chosen microtubule. The total number of microtubules and neurofilaments
in the domain were determined based on the experimentally determined densities of 18/µm2 and
115/µm2, respectively [131]. We thus calculated nM by the formula nM = floor(18piR20) = 56
and similarly we obtained nN = 356. Here the function floor(u) is the largest integer that is
smaller than u. We considered organelles with b = 140 nm and a/b = 10 (Fig. 2C).
We started the simulations by including axonal transport of both neurofilaments and
organelles, mimicking the conditions of normal axons. To distribute the neurofilaments and
microtubules randomly without overlap, we first placed them on a hexagon lattice in D with no
organelles, and then introduced volume exclusion and Brownian motion for enough time to
randomize their positions. Starting from this initial condition, we then turned on the movement
of both neurofilaments and organelles. Fig. 4A is a snapshot of the simulated distribution of
microtubules, neurofilaments, and organelles in a normal axon. The small grey dots are
neurofilaments that are not engaged with microtubules, the small purple dots are neurofilaments
that are engaged with microtubules, the large black dots are microtubules, and the large cyan
circle is an organelle pushing into the cross-sectional domain. Note that a small fraction of the
neurofilaments are bound to microtubules and moving along microtubules, that one microtubule
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can transport multiple cargoes (neurofilaments or organelles), and that one organelle can engage
with multiple microtubules simultaneously.
We then blocked neurofilament transport selectively by resetting the binding rate of
neurofilaments to microtubules, kNon, to be 0 at t = 1h. This disengaged neurofilaments from
their microtubule tracks and thus blocked their movement so that none could enter or leave D.
Meanwhile, the transport of organelles was not affected: they continued to grab microtubules
stochastically, pulling them together. This “zippering” effect caused the microtubules to
gradually cluster (4B). By 6 hours, almost all the microtubules had migrated to the center of D
and formed a single island surrounded by neurofilaments (4C, D). The central microtubule
cluster contained organelles but relatively few neurofilaments whereas the peripheral zone of
neurofilaments contained relatively few microtubules or organelles. This segregation pattern is
strikingly similar to that observed in experiment and in disease, and the rate of segregation is
comparable to that observed experimentally for local injection of IDPN into peripheral nerves of
laboratory animals [24, 131].
After observing segregation, we restored neurofilament transport by resetting kNon to its
original value at t = 13 h. This immediately allowed neurofilaments on the periphery of the
microtubule core within a distance Rb of a microtubule to bind to that microtubule stochastically
and then either unbind or exit D after a short while, as dictated by their stop-and-go transport
behavior. As explained in the Methods, each neurofilament that exited D was replaced with a
new neurofilament seeded adjacent to a randomly selected microtubule, but only if that
microtubule was within a distance of Rb from another neurofilament already in that plane. Over
time this resulted in a gradual infiltration of neurofilaments into the microtubule cluster in a
centripetal manner (i.e. from the outside edges progressing inward), leading to a gradual
dispersal of the microtubules (4E) and a return to their normal interspersed organization (4F).
These results agree tightly with previous experimental findings.
To characterize the reversible segregation of microtubules and neurofilaments, we plotted the
distribution and the mean of the pairwise distance between two microtubules (PDMT) as a
function of time. Figs. 5A and 5B are plots calculated from the simulation shown in Fig. 4,
which demonstrate a significant progressive decrease of the PDMT upon elimination of
neurofilament transport (t = 1h) and subsequent increase upon restoration of neurofilament
transport (t = 13h). Figs. 5C and 5D are plots for a normal axon for comparison. We see that
under normal conditions, because microtubules and neurofilaments are interspersed, the
distribution of PDMT is broad and the mean of it is about 0.8R0; and as microtubules and
neurofilaments segregate from each other, the distribution becomes more compact and the mean
of the PDMT decreases by almost 40%.
Another way to incorporate blockage of neurofilament transport is to increase the off-rate of
neurofilaments kNoff . We performed simulations with k
N
off 100 times larger, and obtained
similar results as in Fig. 4.
Microtubule zippering by moving organelles is the causal mechanism for
segregation.
In the above section we have shown that in the absence of neurofilament transport, organelle
transport leads to microtubule-neurofilament segregation. As we noted earlier, organelles can
interact with multiple microtubules simultaneously and thus pull or zip nearby microtubules
closer together. We next investigated the importance of this zippering mechanism for the
segregation of microtubules and neurofilaments. To do this, we introduced a maximum number
of microtubules that a single organelle can interact with simultaneously, denoted by mmax, and
investigated how the PDMT depends on mmax in the absence of neurofilament transport.
Fig. 6 plots the mean of PDMT as a function of time given different values of mmax. Each
curve is averaged over five realizations with unpredictable seeds, and the error bars indicate the
standard deviations over the realizations. If each organelle is only allowed to bind to one or two
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Figure 5. Statistics of the pairwise distances between microtubules (PDMT). (A, B) IDPN
treatment started at t=1 hour and stopped at t=13 hours. (C, D) control. (A, C) distribution of the
PDMT; data plotted for every 20 min. The pseudo color key represents the number of
microtubule pairs. (B, D) mean of the PDMT; data plotted for every min. Parameters used are
the same as in Fig. 4.
microtubules, i.e., mmax = 1 or 2, then microtubules and neurofilaments remain mixed over
time and segregation does not occur at all (blue and green). Indeed, for mmax = 1, the mean of
PDMT is slightly larger than that for a normal axon shown in Fig. 5D. This is because organelles
stir microtubules and neurofilaments and separate microtubules apart. As mmax increases, the
PDMT curve decreases faster and the time needed to reach complete segregation decreases.
Scatter plots of microtubules and neurofilaments (not shown here) show that for mmax = 4,
partial but significant segregation was observed by 18 hours in all five realizations; for
mmax = 6, complete segregation was observed by 18 hours in four out of five realizations; for
mmax = 8 or 16, complete segregation was observed in all realizations within 10 hours. These
results suggest that microtubule zippering by moving organelles is the causal mechanism for the
segregation of microtubules and neurofilaments in the absence of neurofilament transport.
Dependence on the size and the flux rate of organelles.
We next investigated the dependence of the segregation on the size and the flux rate of the
organelles by simulating the model with different sizes of organelles, b = 140 nm or b = 70 nm,
and different flux rates kOin. Fig. 7 plots the mean PDMT over time for four situations:
b = 140 nm and kOin = 0.105/s (shown in blue), which is the same as in Fig. 4; b = 140 nm
and kOin = 0.1575/s (shown in green); b = 70 nm and k
O
in = 0.105/s (shown in red); and
b = 70 nm and kOin = 0.21/s (shown in cyan). These results suggest that (1) for organelles of
the same size, the more frequently they move through D, the faster the segregation occurs; (2)
given the same flux rate across D, larger organelles are more capable of clustering microtubules
and segregating them from neurofilaments than small organelles, and this is because on average
larger organelles can interact with more microtubules simultaneously.
Interestingly, simulations of the model demonstrate that during the segregation process
microtubules frequently form smaller clusters first, then these small clusters gradually merge
with each other to finally form a single large cluster near the center of the domain. These
intermediate states were more apparent in simulations with small organelles, presumably
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Figure 7. The segregation process depends on organelle size and flux rate. The mean PDMT is
plotted over time. Organelle max radius b: 140 nm for blue and green curves (same as Fig. 4);
b = 70 nm for red and cyan curves. Organelle flux rate kOin: same as Fig. 4 (x1; blue and red),
1.5-fold greater (x1.5; green) and 2-fold greater (x2; cyan). Each curve represents an average of
5 realizations of the model and the error bars are the standard deviation. All other parameters are
the same as in Fig. 4.
because the rate at which the smaller clusters merge is slower under this condition. Figs. 8A-C
are snapshots of these intermediate states captured in a single realization (corresponds to the
cyan curve in Fig. 7). A similar pattern of isolated clusters of microtubules has also been
reported by Zhu et al [73] (Fig. 8D) (see Discussion).
Partial blockage of neurofilament transport: dosage effect.
We finally investigated the cross-sectional distribution of microtubules and neurofilaments when
neurofilament transport is partially blocked. In the case of segregation induced by IDPN, this
might be considered equivalent to varying the IDPN concentration. To do this we reduced kNon
by different extents at t = 0h. Fig. 9 plots the mean of PDMT over time for kNon equals 0.5, 0.2
and 0 times of its original value. Each curve was obtained by averaging over 5 realizations with
unpredictable seeds, and the error bars indicate the standard deviations about the mean. The data
indicate that when kNon is small enough, there is insufficient neurofilament transport to counteract
the organelle-dependent microtubule clustering, and segregation is observed. However, as kNon
becomes larger, the rate of microtubule clustering becomes slower and the resulting clusters
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Figure 8. Intermediate states of the segregation process. (A-C) snapshots of the segregation
process in a single realization. (A) microtubules form three clusters by t = 4h. (B) these
clusters remain separated for several hours until two of them merge around t = 8h. (C) finally
all microtubules form a single big cluster near the center of the domain. The dimension of the
organelles: b = 70nm, a/b = 10. The flux rate of the organelles: 0.21/s. All other parameters
are the same as in Fig. 4. (D) multiple microtubule clusters observed in experiments with IDPN.
Big dots: microtubules; circular objects: organelles. Black arrows point to microtubule islands.
Adapted from Fig. 9A of [73]. The scale bar is 0.4 µm
become less compact, reflecting less efficient segregation. Increasing kNoff has a similar effect:
as kNoff becomes larger, the rate of microtubule clustering becomes faster and the clusters
become more compact (not shown). Thus the rate and extent of microtubule-neurofilament
segregation is dependent on the extent of inhibition of neurofilament transport.
Discussion
Summary of our model. We developed a novel stochastic multiscale model for the
cross-sectional distribution of microtubules and neurofilaments in axons. The model describes
microtubules, neurofilaments, and membranous organelles as interacting particles in an axonal
cross-section. It incorporates detailed descriptions of key molecular processes hat occur within
seconds, including the axonal transport of neurofilaments and membranous organelles through
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deviations. The rate kNon is reduced to 50% (blue), 20% (green), and 0% (red) of the value in Fig.
4 at t = 1h. All other parameters are the same as in Fig. 4.
this plane, as well as volume exclusion and Brownian motion of all the particles, and addresses
the segregation phenomena that occur on a time scale of hours to days. The positions of the
particles in the plane are governed by a system of stochastic differential equations.
Mathematical models of the axonal transport of neurofilaments and organelles have been
developed previously to describe the longitudinal distribution of cargoes along
axons [114–118, 120, 124]. However, those models were in 1D and did not consider the spatial
arrangement and mechanical interactions of the cargoes and tracks in the radial dimension which
are essential in understanding the segregation of microtubules and neurofilaments as well as the
subsequent axonal swelling in neurological diseases. In our model, we describe in detail the
dynamic interactions of neurofilaments, organelles, and nearby microtubules through molecular
motors and volume exclusion in cross-section. Simulations of the model are in tight agreement
with experimental data and generated a number of predictions that can be tested experimentally.
Neurofilament and membranous organelle transports are competing processes. Simulations
of the model demonstrate that if we block neurofilament transport selectively by preventing
neurofilament binding to microtubules, while allowing organelle movement to continue, then the
moving organelles tend to zipper nearby microtubules together so that they gradually segregate
from the neurofilaments. The microtubule zippering action of the membranous organelles arises
because we allow multiple motors to engage with a single organelle, which is consistent with
experimental data and theoretical considerations [89, 90, 121, 129]. Restoration of neurofilament
transport in the model allows the neurofilaments and microtubules to remix until their spatial
distribution returns to normal. This suggests that neurofilament transport and organelle transport
are competing processes in determining the cross-sectional distribution of microtubules:
neurofilament transport can insert neurofilaments between adjacent microtubules, pushing those
microtubules apart, while organelle transport can pull microtubules together when they move
along multiple microtubules simultaneously, similar to a zipper. In normal axons, a dynamic
balance between these two processes leads to the interspersed distribution of microtubules and
neurofilaments, while in the absence of neurofilament transport, the microtubule zippering effect
of organelle transport causes microtubules and neurofilaments to segregate. Thus our model
predicts that the microtubule-neurofilament segregation that is observed in axons in neurotoxic
and neurodegenerative diseases is a simple emergent property of the motile properties of
membranous organelles that is triggered by selective impairment of neurofilament transport. An
important and experimentally testable prediction of this study is that segregation is dependent on
organelle movement.
Why are the microtubule clusters mostly central? An intriguing feature of
microtubule-neurofilament segregation, which is consistent across all published reports, is that
the microtubules generally cluster in the center of the axon, surrounded by a peripheral band of
16
neurofilaments (see Introduction and Fig. 1). It is interesting to note that this was usually the
case in our simulations also. According to our model, the segregation generated by microtubule
clustering is caused by an exclusion of neurofilaments from the microtubule domain due to their
failure to interact. The central location of the microtubule bundle is essentially a boundary effect
which arises because microtubules at the periphery of the axon can only be pulled towards
microtubules that are located more centrally whereas microtubules in the center can be pulled
towards microtubules on all sides. The net result is that microtubule zippering by moving
organelles tends to pull these polymers towards the axon center, displacing the neurofilaments to
the periphery. The organelles co-segregate with the microtubules because they must follow the
available tracks.
Segregation proceeds via the merging of small microtubule clusters. An interesting
observation in our simulations is that microtubule-neurofilament segregation tends to proceed
initially via the formation of small microtubule clusters that subsequently merge together. This
was more apparent in simulations with smaller organelles, which are less efficient at zippering
microtubules together (see discussion below). Multiple small microtubule clusters have been
reported in some studies on microtubule-neurofilament segregation induced by IDPN [54, 73]
(see Fig. 8D), but there is no published time course of segregation so it remains to be proven that
these clusters are indeed intermediate states. Interestingly, microtubule zippering in our
simulations also gives rise to the formation of small microtubule clusters in healthy axons.
However, with ongoing neurofilament transport these clusters are transient and rarely merge to
form larger ones. This is consistent with reports that small clusters of microtubules, often
adjacent to one or more membranous organelles, are commonly observed in electron
micrographs of axons [8, 44, 45, 91].
Factors influencing rate of segregation. Our analysis gives us some insights into the factors
that influence the rate of microtubule-neurofilament segregation. First, given the same number
density, larger organelles are more effective at causing segregation, because they can interact
with more microtubules simultaneously and they can pull together microtubules that are farther
apart. Second, segregation occurs faster if the flux rate of the organelles is larger. Third,
segregation occurs faster if the degree of neurofilament transport impairment is larger. These
predictions are experimentally testable. It is also clear that there must be some dependence on
the density of motors on the organelle surface, as well as the neurofilament:microtubule ratio.
We are currently performing an extensive investigation on how the segregation phenomena
depend on combinations of the model parameters using model simplification,
nondimensionalization and mathematical analysis. These efforts will provide further insight of
the biological problem and will be published elsewhere in the future.
The predicted rate of segregation is comparable to that in real axons. The best experimental
data on the kinetics of microtubule-neurofilament segregation is for animals treated with the
neurotoxin IDPN. However, the rate of segregation in those animals depends on the mode of
administration. When applied systemically to rats using a single intraperitoneal injection,
segregation was first noted after 4 days, and after 4 such injections at 3 day intervals, the
resulting segregation persisted for 6-16 weeks [131]. In contrast, when applied locally at high
concentration by sub-perineurial injection into peripheral nerve, microtubule-neurofilament
segregation was evident after 2 hours, with the microtubule clusters becoming increasingly
compact over the next 4-10 hours [24, 52]. Nagele et al. [57] analyzed the pairwise distance
between microtubules (PDMT) and observed full compaction by 8 hours after injection. Sixteen
hours later, segregation was no longer seen in most axons, indicating an almost complete
reversal [52]. In our simulations, we observed segregation within 4-12 hours of a complete
cessation of neurofilament transport, and remixing within 2-8 hours after a complete resumption
of neurofilament transport. This rate of segregation is comparable to the kinetics observed
experimentally for injections of IDPN into nerves, and suggests that this delivery method results
in a transient but acute inhibition of neurofilament transport. We predict that the slower time
course of segregation that is observed when IDPN is administered systemically is due to the
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lower effective dose experienced by the axons in those studies. The rate of remixing was a bit
shorter in our simulations than in the experimental reports, which may be because we assumed
an instantaneous recovery of neurofilament transport rather than a gradual one, which is more
likely.
What is the mechanism of neurofilament transport impairment? It is important to note that
the impairment of neurofilament transport that leads to microtubule-neurofilament segregation in
toxic neuropathies and neurodegenerative diseases also leads eventually to focal neurofilament
accumulations and axonal swellings (see Introduction). Since microtubules are the tracks along
which neurofilaments move, and since microtubule-neurofilament segregation appears early and
precedes neurofilament accumulation and axonal swelling, it has been hypothesized that the
segregation reflects the uncoupling of neurofilaments from their transport machinery [24, 28].
Our modeling supports this hypothesis, but the molecular mechanism is unclear. Many of the
neurotoxic agents that cause microtubule-neurofilament segregation and impair neurofilament
transport (e.g. hexanedione, IDPN, carbon disulfide) are reactive molecules that could, or are
known to, modify neurofilaments chemically [28]. It is thought that these compounds react with
specific amino acid residues to form protein adducts which may then modify protein interactions,
and that such chemical modifications target neurofilaments preferentially or that they somehow
render these polymers more susceptible than other cargoes to transport impairments. This
selectivity could arise, for example, due to the unique structure or unusual amino acid
composition of neurofilament proteins. The mechanism of impairment could be by interfering
with their interaction with molecular motors or with the interaction of these motors with the
microtubule tracks. Future experimental studies will be required to resolve such questions.
How do neurofilament accumulations arise? The mechanism by which neurofilament
accumulations arise is also of great interest given that this occurs in so many neurodegenerative
diseases. Since local accumulations can only form if more neurofilaments move into a segment
of axon than move out, the appearance of local swellings along axons implies some longitudinal
instabilities in the transport of these cargoes. Therefore we propose that neurofilament
segregation is an early event in neurofilament transport impairment but that longitudinal
instabilities or non-uniformities in the transport impairment must arise to give rise to local
accumulations and axonal swellings. We plan to address this in future studies. Due the complex
spatial and temporal nature of this problem, which entails the interactions of multiple dynamic
components, we believe that a full understanding can only be achieved by a combination of
experimental and modeling approaches. Our present study is an important first step.
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Supporting Information A: calculation methods for the RDF
and OPD in Fig. 3
To calculate the RDF, for each time frame we used the centers of the neurofilaments in the
domain [−0.2µm, 0.2µm]× [−0.2µm, 0.2µm] as reference points. We chose to use reference
points in a smaller domain in order to avoid boundary effects. For each reference point we
binned the center-to-center distances (r) between the reference neurofilament and all other
neurofilaments with a bin size ∆r = 1nm, and normalized by the factor 2pir∆rρN where ρN is
the density of neurofilaments in the whole domain. We then took the average over all reference
points for each time frame and then over all time frames to obtain g(r). We note that g(r) is
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noisy due to under sampling and the small bin size (1 nm). Averaging over more time frames or
using a larger bin size gave smoother g(r). To compute the OPD pn, we used circular windows
with fixed radii 60 nm as in [122]. For each time frame, we sampled centers of 10nN circles
according to the uniform distribution in the domain [−0.3µm, 0.3µm]× [−0.3µm, 0.3µm] and
calculated the particle occupancy number for each circle. We then produced a histogram of
occupancy numbers obtained for all circles and normalized it by the total number of circles to
obtain pn.
Supporting Information B: parameter estimation
The parameters of the model are summarized in Table 1. In the following, we explain the
methods used to estimate the parameters.
Kinetic rates for neurofilament and organelle transports.
We assume that a neurofilament can only bind to a single microtubule at one time whereas an
organelle, which is much larger, can interact simultaneously with one or more microtubules. The
capturing radius Rb for these interactions is taken to be 80 nm, which is the length of a kinesin
motor when fully extended, as measured by electron microscopy [123].
The movement of neurofilaments along axons has been modeled as a bidirectional
independent velocity jump process in 1D with two distinct pausing states in which a
neurofilament either moves anterogradely or retrogradely, pauses for a short time, or pauses for a
long time [124, 125]. Since that model is one dimensional, the kinetic rates extracted represent
space averages over all neurofilaments in the axonal cross-section. For this reason, the kinetic
rates for neurofilament transport in our model are related, but not identical, to the rates extracted
in those other studies. We estimate kNon, the rate at which a neurofilament binds to a nearby
microtubule within distance Rb in our model, to be five times as large as the transition rate γ01,
the rate for a short-pause neurofilament to start moving, defined in [125]. We estimate kNoff , the
unbinding rate of neurofilaments in our model, to be the same as the rate γ10, the rate for a
moving neurofilament to stop and pause, as defined in [125]. Using γ01 = 2.0× 10−3/s and
γ10 = 6.5× 10−2/s for myelinated axons, we obtain kNon = 1.0× 10−2/s and
kNoff = 6.5× 10−2/s.
The rate that a neurofilament leaves the domain, kNout, is estimated in the following way. The
average time for a neurofilament to move through D is LN/sN , where LN is the average length
of moving neurofilaments and sN is the speed of the filament. Assuming that the neurofilament
departure events are exponentially distributed then the rate kNout is the reciprocal of the average
time, i.e., kNout = s
N/LN . Taking LN ≈ 5µm, which is the approximate average length of
moving neurofilaments in cultured neurons, and sN ≈ 0.5µm/s [126, 127], we obtain
kNout = 0.1 s
−1.
The binding and unbinding rates of organelles to a nearby microtubule, kOon and k
O
off , are
assumed to be constant 2/s which are comparable to the rates used in previous mathematical
models of vesicular transport along microtubules [128, 129].
The passage rate for the organelles is calculated using their cross-sectional density.
Assuming the cross-sectional organelle density is ρO, then the total number of organelles in D is
given by piR20ρ
O. Denoting the speed of the organelle along microtubule to be sO and the length
of the organelle to be 2a, then the time that an organelle remains in D is given by 2a/sO.
Assuming that organelle arrival is a Poisson process, then the Poisson rate can be calculated as
piR20ρ
O divided by 2a/sO, that is,
kOin = piR
2
0ρ
OsO/(2a).
The sizes and densities of axonal organelles have been most carefully studied in [130].
According to Table 1 in [130], there are two major sizes of organelles: large ones such as
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mitochondria have an average cross-sectional diameter of 280 nm, and small ones classified as
tubular and vesicular profiles have an average cross-sectional diameter of 50 nm. The densities
of these organelles were counted in longitudinal slices of axons, and need to be converted to
cross-sectional densities for our model. We note that the cross-sectional density (ρO) and the
longitudinal density (denote as ρOl ) are generally different. However, the area fraction occupied
by the organelles averaged over cross sections and longitudinal sections are comparable, and this
relation can be used to convert the longitudinal density to cross-sectional density. Assuming that
the objects are cylinders with radius r and length l, the area fractions measured in cross and
longitudinal sections are given by pir2ρO and 2rlρOl respectively. Equating these two, we obtain
ρO = 2lρOl /(pir). For the large organelles, 2r = 280nm, l = 870nm, ρ
O
l = 0.023/µm
2, and
this leads to ρO = 0.091/µm2. For the small organelles, 2r = 50nm, l = 180nm,
ρOl = 0.02/µm
2, and this leads to ρO = 0.0917/µm2.
The density of organelles estimated above is comparable to the density data in published
IDPN studies. For example, in Table 1 of [131], the mitochondrial density was measured to be
0.187− 0.250/µm2. Taking ρO = 0.187/µm2, a = 10b = 2.8µm, sO = 1µm/s, and
R0 = 1µm, we obtain kOin = piR
2
0ρ
OsO/(2a) = 0.105/s.
Parameters in the pairwise repulsion and elastic spring forces.
We first estimate Lr which is the maximum distance for pairwise repulsions of particles. The
parameter Lr for neurofilament-neurofilament repulsion is approximately 2lN , where lN is the
equilibrium brush thickness of the neurofilament sidearms. This was given by Eqn. (4) in [122],
that is,
lN =
(
12
pi2
)1/3
Na
(a
s
)2/3
. (S1)
Here N is the number of amino acids per sidearm, a is the length of an amino acid and s is the
spacing between neurofilament sidearms. Taking N = 679 [122], a = 3.5 angstroms [132, 133],
and s = 3 nm [122, 134], we obtain lN ≈ 60.6 nm and thus Lr = 121.2 nm. For simplicity, we
use the same Lr for pairwise interactions of all kinds of particles and their interactions with the
domain boundary.
We estimate the force prefactors εkl in the following way. We assume that the repulsion force
between two neurofilaments is approximately 1 pN when their surface distance is d = 40 nm.
Under this assumption we have εNN = 1/(Lr/d− 1). Taking Lr = 121.2 nm, we obtain
εNN ≈ 0.5 pN. We denote εNN by εr for simplicity of notation. We assume that the force
prefactor for microtubule-microtubule, microtubule-neurofilament repulsions and repulsions of
microtubules and neurofilaments with the boundary are the same as εr. For repulsions that
involve organelles, we use a prefactor that is five times as large, that is, εkO = εOk = 5εr.
Organelle movement can cause significant flow of the axoplasm near their surfaces and
displace nearby microtubules and neurofilaments. As an organelle pushes into D, its radius
increases and it pushes nearby fluid and particles away from itself; as it moves away from D,
instead of leaving void behind it, it creates negative pressure which draws the axoplasm to flow
back and fill the space. In this model, we do not include the hydrodynamic interactions among
these particles explicitly, but include this effect by adjusting the force factors ε associated with
organelles. Specifically, when organelles push into the domain, we double εkO and εOk to take
into account the contribution of the fluid flow.
The effective spring constants κN and κO are calculated in the following way. The mean
surface distance between a microtubule and a cargo engaged on it has been observed to be 17 nm
(denote as l0) [135, 136]. We assume that the spring force and the repulsive force between a
microtubule-neurofilament pair equilibrates at l0, i.e., κN l0 = εr(Lr/l0 − 1). From this
assumption we obtain
κN = εr(Lr/l0 − 1)/l0. (S2)
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Plugging the values of εr, Lr and l0 into this expression, we obtain κN = 0.18 pN/nm.
Similarly, we assume that the spring force and the repulsive force of a microtubule-organelle
pair equilibrates at l0, and this leads to
κO = 5εr(Lr/l0 − 1)/l0, (S3)
which is κO = 0.9 pN/nm. We note that the spring constant for a single kinesin motor is
estimated to be 0.2− 0.4 pN/nm in [137]. The spring constants here are different from the
spring constant of a single motor in two ways: first, when a cargo moves along a microtubule
there could be multiple motors being active, and thus the spring constants used here represent
the sum of the spring constants over all active motors; second, the spring constants used here
only take into account projections of the elasticity of individual motors in the plane orthogonal
to the microtubule, whereas molecular motors are most likely slanted when dragging a cargo
along a microtubule.
Drag and diffusion coefficients
We treat neurofilaments as slender cylinders, and estimate the drag coefficient per unit length
(µ/L) by the formula given in [138], µN/L = 4piη/(ln(LN/b) + ln 2− 0.5), where η is the
viscosity of the axoplasm, LN is the characteristic length of the cylinder, and b is the
characteristic radius of the cross-section. The viscosity of the cell cytoplasm is estimated to be
η ∼ 3− 5 pN · s/µm2 for mammalian cells [139, 140] . The persistence length of
neurofilaments is 200-450 nm [141, 142]. The characteristic radius of a neurofilament with its
sidearms is about 20 nm [143]. Taking LN = 500nm , b = 20nm, we obtain
µN/L = 4piη/(ln(LN/b) + ln 2− 0.5) ≈ 14.7 pN · s/µm2. Taking the length of the
neurofilament to be L = 5µm, we obtain µN ≈ 73.5 pN · s/µm.
We estimate the drag coefficient for microtubule in a similar way. The persistence length of
microtubules has been estimated to be 80± 20µm [144]. We estimate the characteristic radius
of the microtubule with its associated proteins in axons to be 37.5 nm. Taking
η = 4 pN · s/µm2, LM = 80µm and b = 37.5 nm, we obtain µM/L = 6.4 pN · s/µm2. We
note that this estimate is close to the estimate obtained by treating microtubules as infinitely long
cylinders, for which one can use the Oseen drag formula µM/L = 4piη/ log(4/Re − γ + 0.5)
where γ ≈ 0.5772 is the Euler’s constant and Re is the Reynolds number [145, 146]. The
characteristic flow velocity in axonal cross-section is approximately U = 0.2µm/s given by the
pushing of the organelles. Assuming that the density of the cytoplasm ρ to be the same as water,
we find that Re = 2Ubρ/η ≈ 4.3× 10−3. Plugging η and Re into the Oseen’s formula, we
obtain the drag per unit length to be 6.3 pN · s/µm2. Taking the sectional length of microtubule
to be L = 80µm, we obtain µM ≈ 6.4× 80 = 512 pN · s/µm.
We estimate the drag coefficient for organelles using the formulas for a prolate ellipsoid
given in [146]. Assume that the major axis of the ellipsoid is 2a and the minor axis is 2b, then
the drag coefficient per unit length is given by
µO/L =
16piηe3
2e+ (3e2 − 1) ln[(1 + e)/(1− e)] for 0 < e < 1,
where e =
√
(1− (b/a)2) is the eccentricity. For b/a = 0.1, 0.2 and 0.5, we have
µO/L ≈ 14.4, 17.9 and 26.0 pN · s/µm2. For organelles with b = 140nm and b/a = 0.1, we
have µO ≈ 40.3pN · sec/µm.
We calculate the diffusion coefficients Dk with k = M,N, and O using the Einstein relation
Dk = kBT/µk, (S4)
where kB is the Boltzmann’s constant and T is the absolute temperature. At room temperature
(25 ◦C or 298 K), one has kBT = 4.11pN · nm. Using µN = 73.5 pN s /µm, we obtain
DN ≈ 5.6× 10−5 µm2/s . We calculated DM and DO in a similar way. Finally σk is given by
the relation σk =
√
2Dk.
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Supporting Information C: simulation algorithm
To solve the model numerically, we chose a time step h much smaller than all the time scales
involved in Mechanisms 1-3, treated the binding and unbinding, arrival and departure of cargoes
explicitly at discrete time steps, and integrated the model system (Eqn. 8 in main text) using the
explicit Euler’s method. Because σk, k = M,N,C are constant in time, the numerical
integrator has strong order 1.0 [147]. For the segregation simulations, we used h = 1/50 sec if
there was no organelle in D; otherwise we used h = 1/1600 sec in order to deal with the
stiffness of the equations introduced by the pushing of organelles when they move into D. The
algorithm for a typical time step is summarized below.
Algorithm for the model
1. Stochastic removal of moving neurofilaments. For each moving neurofilament, generate a
random number r uniformly distributed in [0, 1]. If r < 1− e−kNouth then remove it from
D.
2. Update zOi and r
O
i for each organelle in D according to Eqn. 1 and Eqn. 4 in the main
text. If zOi becomes bigger than or equal to a then remove the i-th organelle and release all
microtubules from it.
3. Stochastic unbinding of cargoes, i.e., neurofilaments and organelles, from their engaged
microtubules. If a microtubule and an organelle are engaged, then generate a random
number r uniformly distributed in [0 1], and let them unbind if r < 1− e−kOoffh. They
also unbind if their surface distance is bigger than Rb. The same method is used to update
microtubule-neurofilament binding.
4. Stochastic binding of cargoes to microtubules.
(a) If the surface distance of a cargo and a microtubule is smaller than Rb, then generate
a random number and determine if they intend to bind to each other. Loop through
all microtubule-neurofilament and microtubule-organelle pairs, and find all potential
binding events.
(b) Accept or reject the potential binding events according to the availability of the
associated microtubules in a random order. We assume that one microtubule has 5
tracks, each neurofilament occupies one track, an organelle with maximum radius
140nm occupies 2 tracks, and an organelle with maximum radius 70nm occupies
1.5 tracks.
5. Addition of new neurofilaments and organelles to D. The number of new neurofilaments
equals the number that has been removed in step 1. The number of new organelles is
determined using the rate kOin. Since the time step h is much smaller than the mean arrival
time of organelles kOin, we introduce a new organelle in each time step with probability
(1− e−kOinh). We then add these cargoes at l0 = 17 nm away from a randomly chosen
microtubule at a random angle. If the random location overlaps with an existing particle or
the associated microtubule is too crowded, then a different microtubule and an angle is
generated randomly. Once a new cargo is added, it is bound to the selected microtubule.
6. Update the positions of the microtubules, organelles and neurofilaments in D by
integrating the model system (Eqn. 8 in the main text) using the explicit Euler’s method,
i.e.,
xki (t+ h) = x
k
i (t) + F
k
i (t)h/µ
k + σkr
k
i
√
h,
1 ≤ i ≤ nk, k = M,N,F.
(S5)
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where rki are pairs of random numbers generated from the standard normal distribution
using the Box-Muller transform [148]. To avoid large values of rki , they are regenerated if
the absolute value of any component is greater than 5.
7. Go to Step 1 for the next time step.
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